Most of patients with localized prostate cancer will be treated in the future? | Opinion: Yes

by Paolo Dell’Oglio, Rafael Sanchez-Salas

The Role of Everolimus in Renal Cell Carcinoma

by Malek Meskawi, Roger Valdivieso, Paolo Dell’Oglio, Vincent Trudeau, Alessandro Larcher, Pierre I Karakiewicz
Published 2015-12-01

Bladder Cancer and Urothelial Impairment: The Role of TRPV1 as Potential Drug Target

by Francesco Mistretta, Nicolò Maria Buffi, Giovanni Lughezzani, Giuliana Lista, Alessandro Larcher, Nicola Fossati, Alberto Abrate, Paolo Dell’Oglio, Francesco Montorsi, Giorgio Guazzoni, Massimo Lazzeri
Published 2014-01-01

Applicability of COVID-19 Pandemic Recommendations for Urology Practice: Data from Three Major Italian Hot Spots (BreBeMi)

by Paolo Dell’Oglio, Giovanni Enrico Cacciamani, Fabio Muttin, Giuseppe Mirabella, Silvia Secco, Marco Roscigno, Federico Alessandro Rovati, Michele Barbieri, Richard Naspro, Angelo Peroni, Antonino Saccà, Federico Pellucchi, Aldo Massimo Bocciardi, Claudio Simeone, Luigi Da Pozzo, Antonio Galfano
Published 2021-04-01

Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.

by Nina Wagener, Dominic Edelmann, Axel Benner, Richard Zigeuner, Hendrik Borgmann, Ingmar Wolff, Laura M Krabbe, Mireia Musquera, Paolo Dell'Oglio, Umberto Capitanio, Tobias Klatte, Luca Cindolo, Matthias May, Sabine D Brookman-May, European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Cancer Group
Published 2017-01-01